IDEXX Laboratories
IDXX
#488
Rank
NZ$81.00 B
Marketcap
NZ$1,014
Share price
-1.38%
Change (1 day)
32.73%
Change (1 year)

P/E ratio for IDEXX Laboratories (IDXX)

P/E ratio as of March 2026 (TTM): 45.5

According to IDEXX Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 45.5474. At the end of 2024 the company had a P/E ratio of 38.4.

P/E ratio history for IDEXX Laboratories from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202438.4-29.66%
202354.68.63%
202250.2-33.31%
202175.32.64%
202073.439.42%
201952.622.55%
201843.0-17.58%
201752.110.24%
201647.334.56%
201535.1-14.67%
201441.236.68%
201330.15.21%
201228.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Abbott Laboratories
ABT
29.8-34.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
27.9-38.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Henry Schein
HSIC
23.9-47.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
35.0-23.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-3.32-107.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Heska Corporation
HSKA
-62.2-236.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Petco
WOOF
-228-599.48%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.